Basically a free 5-10% kicker to full year earnings, which will be recurring. As the transaction is only cleared in February (depending on accounting treatment), it could be even more important than this moving forward (ie when annualised provided baseline growth of 5-10% for the next two years), not including everything else that has been said.
I am very bullish on KME as I think it is at an inflection point in its growth and am looking forward to seeing how things play out over the next 5-10 years as all the benefits of operating leverage start to kick in.
- Forums
- ASX - By Stock
- KME
- Ann: New Zealand Master Franchise
Ann: New Zealand Master Franchise, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KME (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.5¢ |
Change
0.015(3.41%) |
Mkt cap ! $27.00M |
Open | High | Low | Value | Volume |
44.0¢ | 45.5¢ | 44.0¢ | $12.94K | 28.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13805 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.5¢ | 2770 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 439 | 0.915 |
1 | 7582 | 0.910 |
1 | 5524 | 0.905 |
2 | 20484 | 0.900 |
1 | 1149 | 0.870 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 557 | 1 |
0.950 | 12474 | 2 |
0.960 | 53883 | 2 |
0.970 | 20668 | 1 |
0.980 | 27357 | 2 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
KME (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online